{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:04:41Z","timestamp":1784887481190,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi del Piemonte Orientale Amedeo Avogrado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pleural mesothelioma (PM) is a malignancy with a relevant genetic component, with germline mutations identified in up to 12% of cases. International guidelines recommend universal germline testing; however, its implementation in routine clinical practice remains inconsistent. This nationwide survey aimed to assess current clinical practice, attitudes, and barriers related to genetic testing among Italian specialists within the Mesothelioma Team Italy (MET-I) network. A 24-item questionnaire was distributed to MET-I members in 2025, exploring access to testing, clinical use, and perceived obstacles to both germline and somatic DNA sequencing. Forty-five physicians responded (53.6%). Although access to germline testing was relatively high (77.8%), only 6.7% of respondents routinely recommended it. Conversely, somatic NGS was widely available (95.6%) and primarily used for clinical trial screening (66.7%). The main barriers to germline testing included costs (62.2%), limited access to genetic counseling (51.1%), and insufficient physician awareness (48.8%). Despite the availability of genetic testing technologies, germline genetic testing in PM is underutilized in Italy.<\/jats:p>","DOI":"10.1007\/s10689-026-00596-7","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:29:16Z","timestamp":1784885356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey"],"prefix":"10.1007","volume":"25","author":[{"given":"Luigi","family":"Cerbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Perrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ganzinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Luca","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Occhipinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Sculco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on the behalf of MET-I (Mesothelioma team Italy)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"5","key":"596_CR1","first-page":"402","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander HR et al (2019) Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin 69(5):402\u2013429","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"596_CR2","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak J, Sanchez-Vega F, Hoadley KA et al (2018) Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov 8(12):1548\u20131565","journal-title":"Cancer Discov"},{"issue":"28","key":"596_CR3","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou V, Gadiraju M, Wolin A et al (2018) Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol 36(28):2863\u20132871","journal-title":"J Clin Oncol"},{"key":"596_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0352","author":"S Pastorino","year":"2018","unstructured":"Pastorino S, Yoshikawa Y, Pass HI et al (2018) A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2018.79.0352","journal-title":"J Clin Oncol"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","volume":"405","author":"M Betti","year":"2017","unstructured":"Betti M, Casalone E, Ferrante D et al (2017) Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Cancer Lett 405:38\u201345","journal-title":"Cancer Lett"},{"issue":"4","key":"596_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jtho.2019.12.111","volume":"15","author":"R Guo","year":"2020","unstructured":"Guo R, DuBoff M, Jayakumaran G et al (2020) Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas. J Thorac Oncol 15(4):655\u2013660","journal-title":"J Thorac Oncol"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejca.2021.12.023","volume":"163","author":"M Sculco","year":"2022","unstructured":"Sculco M, La Vecchia M, Aspesi A et al (2022) Malignant pleural mesothelioma: germline variants in DNA repair genes may steer tailored treatment. Eur J Cancer 163:44\u201354","journal-title":"Eur J Cancer"},{"issue":"8","key":"596_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1200\/JCO-24-02425","volume":"43","author":"HL Kindler","year":"2025","unstructured":"Kindler HL, Ismaila N, Bazhenova L et al (2025) Treatment of pleural mesothelioma: ASCO guideline update. J Clin Oncol 43(8):1006\u20131038","journal-title":"J Clin Oncol"},{"key":"596_CR9","unstructured":"Italian Association of Medical Oncology (AIOM). Linee Guida Mesotelioma Pleurico [Clinical Practice Guidelines for Pleural Mesothelioma]. 2025 ed. Available from: aiom.it. Accessed July 12, 2026"},{"issue":"5","key":"596_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2026.102550","volume":"28","author":"OD Mitchell","year":"2026","unstructured":"Mitchell OD, Sneider AP, Gilliam K et al (2026) Germline genetic testing and privacy concerns in patients with mesothelioma. Genet Med 28(5):102550","journal-title":"Genet Med"},{"issue":"11","key":"596_CR11","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/s41416-022-01979-0","volume":"127","author":"S Hiltbrunner","year":"2022","unstructured":"Hiltbrunner S, Meerang M, Kirschner MB et al (2022) Genomic landscape of pleural and peritoneal mesothelioma tumours. Br J Cancer 127(11):1997\u20132005","journal-title":"Br J Cancer"},{"issue":"12","key":"596_CR12","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","volume":"31","author":"TA Yap","year":"2025","unstructured":"Yap TA, Kwiatkowski DJ, Dagogo-Jack I et al (2025) YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial. Nat Med 31(12):4281\u20134290","journal-title":"Nat Med"},{"issue":"8","key":"596_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27351","volume":"6","author":"OD Mitchell","year":"2023","unstructured":"Mitchell OD, Jaradeh M, Hathaway C et al (2023) Germline variants incidentally detected via tumor-only genomic profiling of patients with mesothelioma. JAMA Netw Open 6(8):e2327351","journal-title":"JAMA Netw Open"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00596-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:29:17Z","timestamp":1784885357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00596-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00596-7","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}